Sentrx Report issue

For profit Phase 2
Founded: Little Falls NJ United States (2006)
Status: Acquired by Merck (2013)

Organization Overview

First Clinical Trial
2008
NCT00600067
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

phentermine (wyamine) (3 trials)

topiramate (topamax) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Liver Diseases (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2